Summary unavailable.

Questions

Question 1

According to the pharmacologic profile for antivirals, what is the primary use for acyclovir, famciclovir, and valacyclovir?

View answer and explanation
Question 2

For which condition are the antiviral drugs oseltamivir, peramivir, and zanamivir primarily used?

View answer and explanation
Question 3

What is the indicated use for the antiviral agents cidofovir, ganciclovir, valganciclovir, and foscarnet?

View answer and explanation
Question 4

What is the sole indicated use for the antiviral drug vidarabine mentioned in the text?

View answer and explanation
Question 5

What is the general mechanism of action for most antiviral agents as described in the text?

View answer and explanation
Question 6

What is the primary contraindication mentioned for the use of antiviral agents?

View answer and explanation
Question 7

Which antiviral agent is explicitly mentioned as an exception to the rule that requires dose adjustment in patients with renal impairment?

View answer and explanation
Question 8

What are the two potential adverse effects of acyclovir that are highlighted under the 'Precautions' section?

View answer and explanation
Question 9

The antiviral drug Foscarnet is associated with an increased risk of which serious adverse event?

View answer and explanation
Question 10

What is the potential outcome of using acyclovir concurrently with other drugs that cause similar adverse reactions?

View answer and explanation
Question 11

To maintain therapeutic serum drug levels, what is the recommended administration schedule for most systemic antiviral agents?

View answer and explanation
Question 12

What instruction should be given to a patient regarding the duration of their antiviral medication course?

View answer and explanation
Question 13

What is a critical piece of information to convey to a patient about the effect of antiviral medications on virus transmission?

View answer and explanation
Question 14

According to the 'Evaluation/Desired Outcomes' section, the length of time for complete resolution of a viral infection depends on which two factors?

View answer and explanation
Question 15

Which group of antiviral drugs is indicated for the treatment and prevention of oral-facial herpes simplex?

View answer and explanation
Question 16

For a patient prescribed ophthalmic antiviral medications, what specific assessment should be conducted and how often?

View answer and explanation
Question 17

What is the nursing assessment recommendation for a patient using a topical antiviral agent?

View answer and explanation
Question 18

Which of the following is listed as a potential nursing diagnosis for a patient taking antiviral medication?

View answer and explanation
Question 19

What potential nursing diagnosis is specifically related to the effects of viral infections on the skin?

View answer and explanation
Question 20

What should a patient taking antiviral medication be instructed to do if their symptoms do not improve?

View answer and explanation
Question 21

In addition to managing herpes virus infections, acyclovir and valacyclovir are also used for the management of what other condition?

View answer and explanation
Question 22

Which of the following antiviral drugs is specifically indicated for the treatment of cytomegalovirus (CMV) retinitis?

View answer and explanation
Question 23

Besides treatment, what is the other indicated use for docosanol in managing oral-facial herpes simplex?

View answer and explanation
Question 24

According to the 'Precautions' section, which antiviral agent does not typically require a dose adjustment in patients with renal impairment?

View answer and explanation
Question 25

Which antiviral medication is specifically noted to increase the risk of seizures?

View answer and explanation
Question 26

Concurrent use of acyclovir with other nephrotoxic drugs may lead to what additive effect?

View answer and explanation
Question 27

What is the primary reason given for administering most systemic antiviral agents 'around the clock'?

View answer and explanation
Question 28

To prevent the spread of a virus, what is a crucial precaution that patients on antiviral therapy should be taught?

View answer and explanation
Question 29

What is the recommended first step in the nursing assessment of a patient before initiating antiviral therapy?

View answer and explanation
Question 30

What is the primary desired outcome of antiviral therapy as stated in the text?

View answer and explanation
Question 31

Which antiviral medication is used primarily for the prevention of influenza infections?

View answer and explanation
Question 32

Famciclovir is an antiviral agent indicated for the management of which two conditions?

View answer and explanation
Question 33

Valacyclovir is an antiviral agent indicated for the management of which three conditions mentioned in the text?

View answer and explanation
Question 34

What are the two conditions for which acyclovir is indicated as a management therapy?

View answer and explanation
Question 35

What is the fundamental principle of action for the majority of antiviral agents listed?

View answer and explanation
Question 36

The text lists 'Previous hypersensitivity' as a contraindication for antiviral agents. In practical terms, what does this mean for patient care?

View answer and explanation
Question 37

The 'Potential Nursing Diagnoses' section lists 'Impaired skin integrity (Indications).' What does this imply about the conditions being treated?

View answer and explanation
Question 38

What is the most likely clinical reason for the patient teaching instruction to 'continue taking medication... for full course of therapy, even if feeling better'?

View answer and explanation
Question 39

What specific instruction is provided in the 'Patient/Family Teaching' section regarding the application of topical or ophthalmic antiviral preparations?

View answer and explanation
Question 40

The 'Evaluation/Desired Outcomes' section states that the time for complete resolution depends on the 'organism and site of infection.' What does this imply about antiviral therapy?

View answer and explanation
Question 41

For what primary purpose is the antiviral agent peramivir used?

View answer and explanation
Question 42

The antiviral drug foscarnet is indicated for the treatment of which condition?

View answer and explanation
Question 43

What is a key difference in the precautions between zanamivir and most other antivirals mentioned in the text?

View answer and explanation
Question 44

What general nursing assessment should be performed both before and throughout therapy for all patients on antivirals?

View answer and explanation
Question 45

For a patient receiving ophthalmic antivirals, how frequently should eye lesions be assessed?

View answer and explanation
Question 46

What is the therapeutic goal of administering most systemic antiviral agents 'around the clock'?

View answer and explanation
Question 47

A patient on antiviral medication asks if they are no longer contagious. Based on the text, what is the correct advice to provide?

View answer and explanation
Question 48

According to the 'Patient/Family Teaching' section, what should a patient do if the symptoms of their viral infection do not improve?

View answer and explanation
Question 49

The length of time required for the complete resolution of a viral infection is partly dependent on which factor related to the pathogen itself?

View answer and explanation
Question 50

What is the specified use for the antiviral agent penciclovir?

View answer and explanation

Other chapters

HOW TO USE DAVIS'S DRUG GUIDE FOR NURSESEVIDENCE-BASED PRACTICE AND PHARMACOTHERAPEUTICS: Implications for NursesPHARMACOGENOMICSMEDICATION ERRORS: Improving Practices and Patient SafetyDETECTING AND MANAGING ADVERSE DRUG REACTIONSOVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS)SPECIAL DOSING CONSIDERATIONSTHE CYTOCHROME P450 SYSTEMEDUCATING PATIENTS ABOUT SAFE MEDICATION USEAnti-Alzheimer's agentsAntianemicsAntianginalsAntianxiety agentsAntiarrhythmicsAntiasthmaticsAnticholinergicsAnticoagulantsAnticonvulsantsAntidepressantsAntidiabeticsAntidiarrhealsAntiemeticsAntifungalsAntihistaminesAntihypertensivesAnti-infectivesAntineoplasticsAntiparkinson agentsAntiplatelet agentsAntipsychoticsAntipyreticsAntirheumaticsAntiulcer agentsBeta blockersBone resorption inhibitorsBronchodilatorsCalcium channel blockersCentral nervous system stimulantsCorticosteroidsDiureticsHormonesImmunosuppressantsLaxativesLipid lowering agentsMinerals/electrolytes/pH modifiersNonopioid analgesicsNonsteroidal anti-inflammatory agentsOpioid analgesicsSedative/hypnoticsSkeletal muscle relaxantsThrombolyticsVaccines/immunizing agentsVitaminsDRUGS APPROVED IN CANADANATURAL/HERBAL PRODUCTSMEDICATION SAFETY TOOLSAppendix A. Recent Drug ApprovalsAppendix E. Administering Medications to ChildrenAppendix G. Pediatric Dosage CalculationsAppendix I. Controlled Substance SchedulesAppendix L. Insulins and Insulin TherapyAppendix M. Canadian and U.S. Pharmaceutical PracticesAppendix N. Routine Pediatric and Adult Immunizations